Reno-protective Effect of Brain Cooling in Newborn With Hypoxia
NCT02683915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2018-04-03
Summary
This study aims to determine the effect of therapeutic hypothermia on reducing AKI in term and late-preterm infants with hypoxic ischemic encephalopathy as estimated by measurment of serum(s) neutrophil gelatinase-associated lipocalin(NGAL) and serum (s) cystatin-C.
Conditions
- Hypoxic Ischemic Encephalopathy
Interventions
- PROCEDURE
-
Therapeutic hypothermia
Infants in cooled group will be fitted a cooling cap (Olympic Medical Cool Care System, Olympic Medical) around the head for 72 h. infants will be nursed under a radiant overhead heater, which is servo-controlled to the infant's abdominal skin temperature and adjusted to maintain the rectal temperature at 33.5-34.5ºC. At the end of the 72 h cooling period, the infants will be slowly rewarmed at no more than 0•5ºC /h until their temperature become within normal temperature range (36.5-37.5ºC).
Sponsors & Collaborators
-
Mansoura University Children Hospital
lead OTHER
Eligibility
- Min Age
- 30 Minutes
- Max Age
- 24 Hours
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- Egypt
Study Locations
More Related Trials
-
Hypothermia During ECMO to Decrease Brain Injury
NCT01675388 ·Status: WITHDRAWN ·Phase: NA
-
Cooling in Mild Encephalopathy
NCT05889507 ·Status: RECRUITING ·Phase: PHASE3
-
Serum Erythropoietin Level in Perinatal Asphyxia
NCT05018364 ·Status: COMPLETED
-
Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy
NCT00817401 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hypothermia Enhanced by Magnesium Sulphate
NCT02499393 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth
NCT02071394 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
NCT02800018 ·Status: COMPLETED
-
Hypothermia Therapy in Pediatric Cardiac Intensive Care Unit for Suspected for Brain Injury
NCT02395276 ·Status: UNKNOWN ·Phase: NA
-
Amnioinfusion for Intrauterine Neuroprotection
NCT05513690 ·Status: UNKNOWN ·Phase: NA
-
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
NCT02793999 ·Status: RECRUITING
-
Optimising Newborn Nutrition During Therapeutic Hypothermia.
NCT03278847 ·Status: COMPLETED
-
The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy
NCT03835039 ·Status: TERMINATED
-
Cool Prime Comparative Effectiveness Study for Mild HIE
NCT04621279 ·Status: RECRUITING
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3
-
Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
NCT00945789 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Becoming Children With Perinatal Anoxo-Ischemic Encephalopathy Without Indication of Therapeutic Hypothermia
NCT03744481 ·Status: COMPLETED
-
Erythropoietin in HIE Neonate
NCT06590155 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)
NCT02349672 ·Status: COMPLETED
-
MRI Thermal Imaging of Infants Undergoing Cooling for Hypoxic Ischemic Encephalopathy(HIE)
NCT01128673 ·Status: WITHDRAWN
-
Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
NCT02621944 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Melatonin for Neuroprotection Following Perinatal Asphyxia
NCT02071160 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metformin Treatment in Infants After Perinatal Brain Injury
NCT05590676 ·Status: TERMINATED ·Phase: PHASE1
-
Identification of a Pool of miRNA to Improve Early Management of Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy
NCT05986994 ·Status: UNKNOWN
-
Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy
NCT06810284 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
NCT02881970 ·Status: RECRUITING ·Phase: PHASE1/PHASE2